Ignite Creation Date:
2024-05-06 @ 8:18 PM
Last Modification Date:
2024-10-26 @ 3:25 PM
Study NCT ID:
NCT06339281
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-04-19
First Post:
2024-03-05
Brief Title:
A Multicenter Clinical Study of Apatinib Mesylate Combined With Doctors Choice for Advanced Breast Cancer
Sponsor:
Li Huiping
Organization:
Peking University Cancer Hospital Institute
Organization Data
Organization:
Peking University Cancer Hospital Institute
Class:
OTHER
Study ID:
2023YJZ87
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Li Huiping
Lead Sponsor Class:
OTHER
Responsible Party:
Li Huiping
Responsible Party Title:
Director of breast oncology department
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Peking University Cancer Hospital Institute
Old Name:
None
Old Organization:
None